These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7527233)

  • 1. Kinetic analysis of engineered antibody-antigen interactions.
    Malmqvist M
    J Mol Recognit; 1994 Mar; 7(1):1-7. PubMed ID: 7527233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering antibodies for stability and efficient folding.
    Honegger A
    Handb Exp Pharmacol; 2008; (181):47-68. PubMed ID: 18071941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutational analysis of binding interactions in an antigen-antibody protein-protein complex.
    Dall'Acqua W; Goldman ER; Lin W; Teng C; Tsuchiya D; Li H; Ysern X; Braden BC; Li Y; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 1998 Jun; 37(22):7981-91. PubMed ID: 9609690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen.
    Li Y; Urrutia M; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 2003 Jan; 42(1):11-22. PubMed ID: 12515535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based improvement of the biophysical properties of immunoglobulin VH domains with a generalizable approach.
    Ewert S; Honegger A; Plückthun A
    Biochemistry; 2003 Feb; 42(6):1517-28. PubMed ID: 12578364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
    J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the importance of second sphere residues in an esterolytic antibody by phage display.
    Arkin MR; Wells JA
    J Mol Biol; 1998 Dec; 284(4):1083-94. PubMed ID: 9837728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
    Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
    J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of biosensor technology for the engineering of antibodies and enzymes.
    Huber A; Demartis S; Neri D
    J Mol Recognit; 1999; 12(3):198-216. PubMed ID: 10398410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
    Wang Y; Li X; Chen W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody).
    Heng BC; Cao T
    Med Hypotheses; 2005; 64(6):1105-8. PubMed ID: 15823695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides.
    Knappik A; Ge L; Honegger A; Pack P; Fischer M; Wellnhofer G; Hoess A; Wölle J; Plückthun A; Virnekäs B
    J Mol Biol; 2000 Feb; 296(1):57-86. PubMed ID: 10656818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage display of chelating recombinant antibody libraries.
    Wright MJ; Deonarain MP
    Mol Immunol; 2007 Apr; 44(11):2860-9. PubMed ID: 17353051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine mapping of the antigen-antibody interaction of scFv215, a recombinant antibody inhibiting RNA polymerase II from Drosophila melanogaster.
    Liu Z; Song D; Kramer A; Martin AC; Dandekar T; Schneider-Mergener J; Bautz EK; Dübel S
    J Mol Recognit; 1999; 12(2):103-11. PubMed ID: 10398401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamics and kinetics of the reaction of a single-chain antibody fragment (scFv) with the leucine zipper domain of transcription factor GCN4.
    Weber-Bornhauser S; Eggenberger J; Jelesarov I; Bernard A; Berger C; Bosshard HR
    Biochemistry; 1998 Sep; 37(37):13011-20. PubMed ID: 9737882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.